Legend Biotech Corp banner

Legend Biotech Corp
NASDAQ:LEGN

Watchlist Manager
Legend Biotech Corp Logo
Legend Biotech Corp
NASDAQ:LEGN
Watchlist
Price: 18.025 USD -2.25% Market Closed
Market Cap: $3.3B

Wall Street
Price Targets

LEGN Price Targets Summary
Legend Biotech Corp

Wall Street analysts forecast LEGN stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for LEGN is 65.798 USD with a low forecast of 21.21 USD and a high forecast of 95.55 USD.

Lowest
Price Target
21.21 USD
18% Upside
Average
Price Target
65.798 USD
265% Upside
Highest
Price Target
95.55 USD
430% Upside
Legend Biotech Corp Competitors:
Price Targets
ELAN
Elanco Animal Health Inc
8% Upside
RLMD
Relmada Therapeutics Inc
93% Upside
NN
NextNav Inc
18% Upside
WLFC
Willis Lease Finance Corp
-15% Downside
SUPN
Supernus Pharmaceuticals Inc
17% Upside

Revenue
Forecast

53% / Year
Past Growth
43% / Year
Estimated Growth
Estimates Accuracy
-10%
Average Miss
53% / Year
Past Growth
43% / Year
Estimated Growth
Estimates Accuracy
-10%
Average Miss

For the last 6 years the compound annual growth rate for Legend Biotech Corp's revenue is 53%. The projected CAGR for the next 4 years is 43%.

Operating Income
Forecast

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
14%
Average Beat
N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
14%
Average Beat

Net Income
Forecast

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
7%
Average Beat
N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
7%
Average Beat
Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.

What is LEGN's stock price target?
Price Target
65.798 USD

According to Wall Street analysts, the average 1-year price target for LEGN is 65.798 USD with a low forecast of 21.21 USD and a high forecast of 95.55 USD.

What is Legend Biotech Corp's Revenue forecast?
Projected CAGR
43%

For the last 6 years the compound annual growth rate for Legend Biotech Corp's revenue is 53%. The projected CAGR for the next 4 years is 43%.

Back to Top
Get AI-powered insights for any company or topic.
Open AI Assistant

Intrinsic Value is all-important and is the only logical way to evaluate the relative attractiveness of investments and businesses.

Warren Buffett